Johnston Ian A
Known title: Chief Financial OfficerCIK: 0002069237
Johnston Ian A's purchase track record
How the stock did after each of Johnston Ian A's open-market purchases, measured from the purchase date. Several fills within a week count as one purchase.
Purchases measured
3
of 3 since August 8, 2025
Stock higher 6 months later
33%
3 months: 33%
Median 6-month return
-28.4%
3 months: -10.1%
Beat the S&P 500
33%
median -40.9% vs. index
| Purchase | Stock | Amount | 3 months | 6 months | S&P 500, 6 mo. |
|---|---|---|---|---|---|
| 3/10/2026 | AMRZ | $250K | -10.1% | -28.4% | +13.2% |
| 2/19/2026 | AMRZ | $77K | -20.2% | -29.5% | +11.4% |
| 8/8/2025 | AMRZ | $501K | +3.7% | +22.5% | +8.5% |
Computed by MarketWall from SEC Form 4 filings and daily closing prices (close on the purchase date to the close about 3 and 6 months later). Companies that have since delisted are not included. Past results, not investment advice.
Associated companies
Transaction History
| AMRZ | ▲ Buy | Open Market | 4,250 | $250K | 3/10/2026 | View on chart |
| AMRZ | ▲ Buy | Grant | 4,257 | $0 | 2/27/2026 | View on chart |
| AMRZ | ▼ Sell | Tax Withholding | 1,941 | $126K | 2/27/2026 | View on chart |
| AMRZ | ▲ Buy | Open Market | 995 | $64K | 2/19/2026 | View on chart |
| AMRZ | ▲ Buy | Open Market | 205 | $13K | 2/19/2026 | View on chart |
| AMRZ | ▲ Buy | Open Market | 1,459 | $70K | 8/8/2025 | View on chart |
| AMRZ | ▲ Buy | Open Market | 1,041 | $50K | 8/8/2025 | View on chart |
| AMRZ | ▲ Buy | Open Market | 750 | $36K | 8/8/2025 | View on chart |
| AMRZ | ▲ Buy | Open Market | 575 | $27K | 8/8/2025 | View on chart |
| AMRZ | ▲ Buy | Open Market | 500 | $24K | 8/8/2025 | View on chart |
| AMRZ | ▲ Buy | Open Market | 300 | $14K | 8/8/2025 | View on chart |
| AMRZ | ▲ Buy | Open Market | 150 | $7K | 8/8/2025 | View on chart |
| AMRZ | ▲ Buy | Open Market | 111 | $5K | 8/8/2025 | View on chart |
| AMRZ | ▲ Buy | Open Market | 5,370 | $256K | 8/8/2025 | View on chart |
| AMRZ | ▲ Buy | Open Market | 100 | $5K | 8/8/2025 | View on chart |
| AMRZ | ▲ Buy | Open Market | 100 | $5K | 8/8/2025 | View on chart |
| AMRZ | ▲ Buy | Open Market | 44 | $2K | 8/8/2025 | View on chart |
| AMRZ | ▼ Sell | Other | 6,844 | $0 | 6/23/2025 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 17, 2026
JP Morgan cuts Amrize price target to $48, maintains Neutral
JP Morgan has lowered its price target for Amrize to $48 while keeping a Neutral rating. This move comes as the company prepares to announce its third-quarter 2026 financial results. Recent reports also highlight the firm's regional scale and pricing power, though the current analyst target sits below the average consensus of $47.20.
JP Morgan cuts Amrize price target to $48, maintains Neutral. JP Morgan has lowered its price target for Amrize to $48 while keeping a Neutral rating. This move comes as the company prepares to announce its third-quarter 2026 financial results. Recent reports also highlight the firm's regional scale and pricing power, though the current analyst target sits below the average consensus of $47.20.